CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION

Por N. V. Furman, S. S. Shmatova
Publicado em 2015-09-01

CLINICAL SIGNIFICANCE OF DRUGINDUCED INTERVALS QT AND QTC PROLONGATION

Por N. V. Furman, S. S. Shmatova
Publicado em 2015-09-01

QT and QTa interval duration and dispersion during stress test in coronary heart disease and ventricular arrhythmia patients

Por N. V. Furman, S. S. Shmatova, P. Ya. Dovgalevsky
Publicado em 1970-01-01

Diagnosing hemodynamically important coronary atherosclerosis in stable angina patients: the role of stress test dynamics of QT duration and dispersion

Por N. V. Furman, P. Ya. Dovgalevsky, S. S. Shmatova
Publicado em 2008-06-01

A CASE OF PAINLESS MYOCARDIAL INFARCTION DUE TO BRIDGING OF LEFT ANTERIOR DESCENDING ARTERY

Por O. S. Bogomolova, N. V. Furman, I. V. Titkov
Publicado em 2014-07-01

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES

Por P. J. Dovgalevsky, N. V. Furman, N. F. Puchinian
Publicado em 2016-01-01

ANALYSIS OF PRE-HOSPITAL TREATMENT OF ACUTE CORONARY SYNDROME

Por O. V. Reshetko, R. M. Magdeev, N. V. Furman
Publicado em 2015-12-01

THE STRUCTURE OF DRUG PRESCRIPTION IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION ON THE FIRST DAY OF HOSPITAL THERAPY

Por O. V. Reshetko, N. V. Furman, R. M. Magdeev
Publicado em 2016-01-01

RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA

Por N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi
Publicado em 2015-12-01

PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION

Por N. V. Mikheeva, O. V. Reshetko, N. V. Furman
Publicado em 2015-09-01

Plasma D-dimer level value in pulmonary artery thromboembolia diagnostics

Por N. V. Furman, A. R. Kiselev, P. Ya. Dovgalevsky
Publicado em 2006-08-01

RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA

Por N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi
Publicado em 2015-12-01

PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE TREATMENT OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION IN EVERY DAY CLINICAL PRACTICE

Por I. V. Graifer, O. V. Reshet'ko, N. V. Furman
Publicado em 2016-01-01

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION

Por E. A. Protasova, N. V. Furman, O. V. Reshet'ko
Publicado em 2015-12-01

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)

Por O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov
Publicado em 2020-11-01

COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015

Por O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman
Publicado em 2018-03-01

MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE

Por N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya
Publicado em 2017-03-01

High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in p...

Por N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
Publicado em 2016-09-01

RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID

Por N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky
Publicado em 2016-01-01

INCREASED PLASMA LEVEL OF D-DIMER AS A MARKER OF HIGH ARTERIAL THROMBOSIS RISK

Por N. V. Furman, N. F. Puchinjan, O. M. Ansimova, P. J. Dovgalevsky
Publicado em 2016-01-01